NICE's threshold for end-of-life, life-extending interventions? Clinical study 14 January 2013 Pages: 2 - 2
Variable out-of-pockets costs for oral oncology therapies in the US Clinical study 14 January 2013 Pages: 2 - 2
Routine Rotarix vaccination cost effective in Canada and Germany News item 14 January 2013 Pages: 6 - 6
Omalizumab for severe allergic asthma: cost effective all round? News item 14 January 2013 Pages: 7 - 7
Pioglitazone: an effective use of health resources in Italy Clinical study 14 January 2013 Pages: 7 - 7
Dabigatran etexilate: a dab hand for stroke prevention in AF Clinical study 14 January 2013 Pages: 8 - 8
Dexamethasone intravitreal implant a sight for sore eyes Clinical study 14 January 2013 Pages: 11 - 11
Health information technology is the key for chronic diseases Media release 14 January 2013 Pages: 12 - 12
Is peri-operative chemo worth it for resectable liver metastases? Clinical study 14 January 2013 Pages: 12 - 12
Rapid adoption of ipilimumab and vemurafenib for melanoma Media release 14 January 2013 Pages: 12 - 12
A switch in TNF-α inhibitor therapy increases costs for RA Clinical study 14 January 2013 Pages: 13 - 13
Evidence-based guidelines for treating colon cancer saves costs Media release 14 January 2013 Pages: 13 - 13
Liraglutide leads over the long-term for T2DM in 6 countries Clinical study 14 January 2013 Pages: 13 - 13
Medicare disease-management programme falls short of aims Clinical study 14 January 2013 Pages: 13 - 13
Clodronic acid best for metastatic bone disease in Brazil Clinical study 14 January 2013 Pages: 14 - 14
Low-dose aspirin plus endoscopy cost effective for CRC prevention Clinical study 14 January 2013 Pages: 14 - 14
Self-monitoring for T2DM in Canada: what do the models say? Clinical study 14 January 2013 Pages: 14 - 14